bnt162b2 mrna vaccination Search Results


90
Hirotsu Bio Science Inc bnt162b2 mrna vaccine
Brief information of clusters in the co-citation network.
Bnt162b2 Mrna Vaccine, supplied by Hirotsu Bio Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnt162b2+mrna+vaccination/pmc09746488-39-12-4?v=Hirotsu+Bio+Science+Inc
Average 90 stars, based on 1 article reviews
bnt162b2 mrna vaccine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
SYNLAB International GmbH bnt162b2 mrna covid-19 vaccine comirnaty
Brief information of clusters in the co-citation network.
Bnt162b2 Mrna Covid 19 Vaccine Comirnaty, supplied by SYNLAB International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnt162b2+mrna+vaccination/pmc09566572-33-28-16?v=SYNLAB+International+GmbH
Average 90 stars, based on 1 article reviews
bnt162b2 mrna covid-19 vaccine comirnaty - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Makoto USA Inc bnt162b2 mrna vaccine
COVID-19 Related Articles (in Order of Number of Citations).
Bnt162b2 Mrna Vaccine, supplied by Makoto USA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnt162b2+mrna+vaccination/pmc10749803-12-6-30?v=Makoto+USA+Inc
Average 90 stars, based on 1 article reviews
bnt162b2 mrna vaccine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Eurofarma Laboratorios bnt162b2 mrna vaccine
COVID-19 Related Articles (in Order of Number of Citations).
Bnt162b2 Mrna Vaccine, supplied by Eurofarma Laboratorios, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnt162b2+mrna+vaccination/pmc09835740-221-36-48?v=Eurofarma+Laboratorios
Average 90 stars, based on 1 article reviews
bnt162b2 mrna vaccine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CureVac Inc mrna vaccine bnt162b2
Summary of SARS-CoV-2 vaccine strategies with their advantages and limitations.
Mrna Vaccine Bnt162b2, supplied by CureVac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnt162b2+mrna+vaccination/pmc08615473-1-2-29?v=CureVac+Inc
Average 90 stars, based on 1 article reviews
mrna vaccine bnt162b2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Brief information of clusters in the co-citation network.

Journal: Human Vaccines & Immunotherapeutics

Article Title: Emerging trends of research on mRNA vaccines: A co-citation analysis

doi: 10.1080/21645515.2022.2110409

Figure Lengend Snippet: Brief information of clusters in the co-citation network.

Article Snippet: #8 , 50 , Hirotsu, Y (2021) Robust antibody responses to the bnt162b2 mRNA vaccine occur within a week after the first dose in previously infected individuals and after the second dose in uninfected individuals , 116 , - , 0.06 , Dan JM2021Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , SCIENCE.

Techniques: Activity Assay, Activation Assay, Virus, Expressing, Molecular Weight, Polymer, Infection, Wilms Tumor Assay, Bioprocessing, Variant Assay, Vaccines

Main citing articles and cited references in each cluster.

Journal: Human Vaccines & Immunotherapeutics

Article Title: Emerging trends of research on mRNA vaccines: A co-citation analysis

doi: 10.1080/21645515.2022.2110409

Figure Lengend Snippet: Main citing articles and cited references in each cluster.

Article Snippet: #8 , 50 , Hirotsu, Y (2021) Robust antibody responses to the bnt162b2 mRNA vaccine occur within a week after the first dose in previously infected individuals and after the second dose in uninfected individuals , 116 , - , 0.06 , Dan JM2021Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , SCIENCE.

Techniques: Vaccines, Activity Assay, In Vivo, Immunopeptidomics, Molecular Weight, Polymer, In Vitro, Synthesized, Virus, Infection, Selection, Variant Assay, Expressing, Activation Assay, Modification, Inhibition, Bioprocessing, Wilms Tumor Assay, Quantitative Proteomics, Gene Expression, Generated, RNA Sequencing, Genome Wide, Electroporation, Plasmid Preparation, Control, Comparison

COVID-19 Related Articles (in Order of Number of Citations).

Journal: Internal Medicine

Article Title: Internal Medicine Year in Review 2022

doi: 10.2169/internalmedicine.2266-23

Figure Lengend Snippet: COVID-19 Related Articles (in Order of Number of Citations).

Article Snippet: 11 , Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G , Hibino Makoto, et al , 4 , 2022 , 61 , 6 , 811 , 819.

Techniques: Control, Comparison, Variant Assay, Infection

Summary of SARS-CoV-2 vaccine strategies with their advantages and limitations.

Journal: Biomedicines

Article Title: Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges

doi: 10.3390/biomedicines9111740

Figure Lengend Snippet: Summary of SARS-CoV-2 vaccine strategies with their advantages and limitations.

Article Snippet: 2 , mRNA vaccine , Easy to design, lower risk of accidental infection than viral vaccines , Carrier required to stabilize and pack naked RNA , BNT162b2, mRNA-1273, ARCoV, CureVac (Tübingen, Germany).

Techniques: Immunopeptidomics, Vaccines, Infection, Recombinant, Plasmid Preparation, Control, Virus

Forerunners in clinical trials: possible candidates for future.

Journal: Biomedicines

Article Title: Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges

doi: 10.3390/biomedicines9111740

Figure Lengend Snippet: Forerunners in clinical trials: possible candidates for future.

Article Snippet: 2 , mRNA vaccine , Easy to design, lower risk of accidental infection than viral vaccines , Carrier required to stabilize and pack naked RNA , BNT162b2, mRNA-1273, ARCoV, CureVac (Tübingen, Germany).

Techniques: Clinical Proteomics, Vaccines, Recombinant, Adjuvant, Modification, Variant Assay, Virus, Binding Assay, In Vitro, Activity Assay, Plasmid Preparation, Formulation

Vaccines currently in the final phase of clinical trial. Protein subunit vaccines (9) dominate the list followed by mRNA vaccine and recombinant viral vector (3 each). Each of live attenuated, inactivated, virus like particles, and DNA vaccines are in the final phase trial.

Journal: Biomedicines

Article Title: Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges

doi: 10.3390/biomedicines9111740

Figure Lengend Snippet: Vaccines currently in the final phase of clinical trial. Protein subunit vaccines (9) dominate the list followed by mRNA vaccine and recombinant viral vector (3 each). Each of live attenuated, inactivated, virus like particles, and DNA vaccines are in the final phase trial.

Article Snippet: 2 , mRNA vaccine , Easy to design, lower risk of accidental infection than viral vaccines , Carrier required to stabilize and pack naked RNA , BNT162b2, mRNA-1273, ARCoV, CureVac (Tübingen, Germany).

Techniques: Vaccines, Recombinant, Plasmid Preparation, Virus